Although serum NLRP3 has potential for diagnosing and predicting prognosis in sepsis, its clinical application is still in its infancy, and it remains uncertain whether it will eventually be adopted as a standard biomarker in clinical practice. This evidence concerns the gene NLRP3 and Sepsis.